PALI compared with IVVD: revenue, margins and what each company keeps, and the suppliers and customers both name

PALIPalisade Bio, Inc.

Mkt capRevenueRevenue

IVVDInvivyd, Inc.

Mkt capRevenueRevenue

Compare

PALIPalisade Bio, Inc.

IVVDInvivyd, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

PALI, solidIVVD, dashed

Supply-chain overlap

Revenue flow

PALI: latest quarter is a loss; flow not drawable. IVVD: latest quarter is a loss; flow not drawable.Method ›

PALIPalisade Bio, Inc.

1.17▼−1.97%· post 1.16

Mkt cap$202.2MRevenue$500,000Q2 FY26Revenue—

IVVDInvivyd, Inc.

0.59▼−2.76%· post 0.59

ClosedOct 30 '26

Mkt cap$171.5MRevenue$14MQ2 FY26Revenue$53MFY25

Compare

ClosedOct 30 '26

PALIPalisade Bio, Inc.

IVVDInvivyd, Inc.

1.17▼−1.97%post 1.16

Price

0.59▼−2.76%post 0.59

$202.2M

Mkt cap

$171.5M

Q2 FY26$500,000

Revenue

$14MQ2 FY26

—

Revenue

$53MFY25

PALI1.17▼−1.97%vsIVVD0.59▼−2.76%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PALI 2

—Giiant Pharmaunlistedsupplier

—Newsoaraunlistedcustomer

Shared 0

No shared counterparties.

Only IVVD 9

—Undisclosed specialty distributor customerunlistedcustomer

—Adimabunlistedsupplier

—WuXi Biologicsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—WuXi Biologics (Hong Kong)unlistedsupplier

5 more · IVVD chain ›